Aetna Choice POS II BCBS Blue Card PPO CIGNA HMO CIGNA Open Access CIGNA PPO First Health PPO Great West PPO
Harvard Pilgrim HMO Multiplan PHCS PPO Multiplan PPO Tufts Health Plan PPO United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO
Affiliated Hospitals
Miriam Hospital Providence, RI Rhode Island Hospital Providence, RI Women and Infants Hospital of Rhode Island Providence, RI
Dr. William Sikov's Videos
Dr. William Sikov on Triple-Negative Breast Cancer Patients Not Responding to Treatment
William Sikov, MD, associate director of Clinical Research, Program in Women’s Oncology, Women and Infants Hospital of Rhode Island, on the phase II CALGB 40603 trial, which tested if standard neoadjuvant chemotherapy plus carboplatin and/or bevacizumab would result in a pathologic complete response in patients with stage II/III triple-negative breast cancer.
For more resources and information regarding anticancer targeted therapies: